MannKind Corp (MNKD): Free Cash Flow
$13.69M
Year ended 2025-12-31
-$18.14M
Trailing 12 months to 2026-06-30
| Period ended | Free Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $13.69M | -58.3% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $32.82M | n/m | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | -$8.35M | n/m | 2026-02-26, From 2023-01-01 |
| 2022-12-31 | -$88.27M | n/m | 2025-02-26, From 2022-01-01 |
| 2021-12-31 | -$73.17M | n/m | 2024-02-27, From 2021-01-01 |
| 2020-12-31 | -$28.93M | n/m | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | -$91.05M | n/m | 2021-02-25, From 2019-01-01 |
| 2018-12-31 | -$38.09M | n/a | 2020-02-25, From 2018-01-01 |
| No annual figure between 2016-12-31 and 2018-12-31. | |||
| 2016-12-31 | -$79.23M | n/m | 2019-02-26, From 2016-01-01 |
| 2015-12-31 | -$67.52M | n/m | 2018-02-27, From 2015-01-01 |
| 2014-12-31 | -$20.01M | n/m | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | -$136.72M | n/m | 2016-03-15, From 2013-01-01 |
| 2012-12-31 | -$120.50M | n/m | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | -$130.69M | n/m | 2014-03-03, From 2011-01-01 |
| 2010-12-31 | -$158.20M | n/m | 2013-03-18, From 2010-01-01 |
| 2009-12-31 | -$202.94M | n/a | 2012-03-15, From 2009-01-01 |
Free Cash Flow at similar companies
| Company | Year ended | Free Cash Flow | Change YoY |
|---|---|---|---|
| MannKind Corp (MNKD) | 2025-12-31 | $13.69M | -58.3% |
| Arcutis Biotherapeutics, Inc. (ARQT) | 2025-12-31 | -$6.31M | n/m |
| Sinovac Biotech Ltd (SVA) | 2025-12-31 | -$561.10M | n/m |
| CorMedix Inc. (CRMD) | 2025-12-31 | $172.79M | n/m |
| Ardelyx, Inc. (ARDX) | 2025-12-31 | -$43.98M | n/m |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$45.71M | n/m |
| Ironwood Pharmaceuticals Inc (IRWD) | 2025-12-31 | $127.01M | +22.8% |
| Innoviva, Inc. (INVA) | 2025-12-31 | $195.80M | +3.9% |
| Harrow, Inc. (HROW) | 2025-12-31 | $42.98M | n/m |
Compare MNKD, ARQT, SVA, CRMD side by side · Screen every company in Pharmaceutical Preparations ↗